aiwiki.page
English
Science / Chemistry / phosphatidylcholine

Phosphatidylcholine

Phosphatidylcholine is a major membrane phospholipid involved in cellular structure, lipid transport, pulmonary function, and choline metabolism.

37 keywords4 linked from10 not yet writtenWritten by AI
PhospholipidCell MembraneStereochemistryPhosphodiester B…WaterMolar MassHydrolysisChromatographyPhosphatid…

Phosphatidylcholine is a class of phospholipids characterized by a phosphocholine head group attached to a glycerol-based lipid backbone. It is a major constituent of the cell membranes of animals and many other organisms, and an abundant phospholipid in blood lipoproteins, bile, and pulmonary surfactant. The name denotes a family of molecular species rather than a single chemical compound: phosphatidylcholines share a head group but differ in the length, saturation, and linkage of their hydrocarbon chains.

Phosphatidylcholine helps establish the physical properties of membranes, supplies material for lipid transport and secretion, and participates in the metabolism of choline and fatty acids. Its synthesis and breakdown connect membrane growth to nutrient availability and cellular signaling. Individual molecular species can have sharply different functions, exemplified by the importance of dipalmitoylphosphatidylcholine in preventing collapse of the lung’s small air spaces. Phosphatidylcholine is also an important component of commercial lecithins and a widely used material in membrane research and pharmaceutical formulations.

Chemical structure and nomenclature

The conventional diacyl form of phosphatidylcholine consists of a glycerol molecule bearing two fatty acyl groups and a phosphate-linked choline group. The fatty acids are esterified to the first and second positions of glycerol, designated snsn-1 and snsn-2, while phosphocholine occupies the snsn-3 position. The prefix snsn, meaning stereospecific numbering, specifies the orientation of the glycerol backbone and avoids ambiguity arising from its stereochemistry. The systematic class name is 1,2-diacyl-snsn-glycero-3-phosphocholine. The phosphate forms a phosphodiester linkage between glycerol and choline.

Choline contains a quaternary ammonium group, whose nitrogen carries a permanent positive charge. Under ordinary physiological conditions, the phosphate group carries a negative charge, making the head group zwitterionic and approximately neutral overall. Electrical neutrality does not mean an absence of electrostatic interactions: the separated charges interact strongly with water, dissolved ions, and other membrane components. The large, hydrated head group and nonpolar hydrocarbon chains make phosphatidylcholine amphiphilic. This combination is central to its self-assembly in aqueous environments.

Different fatty acids produce chemically and physically distinct phosphatidylcholines. Dipalmitoylphosphatidylcholine, usually abbreviated DPPC, contains two palmitoyl chains, each with 16 carbon atoms and no double bonds. Its molecular formula is C40H80NO8P\mathrm{C_{40}H_{80}NO_8P}. Palmitoyloleoylphosphatidylcholine, or POPC, contains one palmitoyl chain and one oleoyl chain; dioleoylphosphatidylcholine, or DOPC, contains two oleoyl chains. These compounds differ in molar mass, chain packing, oxidation susceptibility, and phase behavior. Consequently, a property measured for purified DPPC cannot automatically be assigned to every member of the class.

Modern lipid notation distinguishes several levels of structural knowledge. PC 34:1 indicates a total of 34 carbon atoms and one double bond across the two hydrocarbon chains, without necessarily identifying either chain. PC 16:0_18:1 identifies their compositions but leaves their positions unspecified; PC 16:0/18:1 assigns them to snsn-1 and snsn-2, respectively. Even the latter notation does not by itself specify the position or geometry of the double bond. Ether-linked choline glycerophospholipids also occur, including alkyl ether and vinyl ether forms, and require additional notation.

“Lecithin” has a broader and historically variable meaning. In older biochemical writing it often denotes phosphatidylcholine itself. In food manufacture and commerce, lecithin usually denotes a mixture of phospholipids and other lipids obtained from materials such as soybeans, sunflower seeds, or egg yolk. Commercial lecithin therefore is not synonymous with chemically pure phosphatidylcholine, and its composition depends on its source and processing.

Historical discovery and methods of investigation

Phosphatidylcholine emerged from nineteenth-century investigations of phosphorus-containing substances in animal tissues. In 1846, the French chemist Théodore Gobley isolated a phosphorus-containing lipid material from egg yolk; in 1850 he introduced the name lecithin, derived from the Greek word for egg yolk. His work established that substances of this kind were not confined to a single tissue. The distinction between individual phospholipid classes and heterogeneous extracts developed gradually as chemical separation and structural analysis improved.

Early analysis depended heavily on chemical degradation. Investigators identified products released by hydrolysis, including fatty acids, glycerol-related compounds, phosphate, and choline, and used their proportions to infer the parent molecule’s structure. Such methods established the major building blocks but could obscure the diversity of molecular species. An egg-yolk extract containing many different phosphatidylcholines could appear comparatively uniform when characterized only by its shared phosphorus and choline content. Recognition of lipid heterogeneity became increasingly important as analytical methods gained resolving power.

During the twentieth century, solvent extraction and chromatography made it possible to separate phosphatidylcholine from other lipid classes. The chloroform–methanol extraction procedure described by Jordi Folch and colleagues in 1957 became especially influential in tissue lipid analysis. Thin-layer chromatography subsequently offered a convenient way to distinguish phospholipid classes. Phosphorus assays quantified total phospholipid content, while analysis of fatty acid derivatives by gas chromatography revealed chain composition. Each approach measured a different feature: knowing the total fatty acid composition of a sample did not establish which two chains occurred together in an individual molecule.

Contemporary lipidomics relies extensively on liquid chromatography coupled to mass spectrometry. In positive-ion tandem mass spectra, many phosphatidylcholines produce a prominent phosphocholine fragment at approximately m/z 184.073m/z\ 184.073. This fragment is useful for detection but is not unique to phosphatidylcholine, because sphingomyelin also contains phosphocholine. Identification therefore combines precursor mass, chromatographic behavior, and additional fragmentation evidence. Stable-isotope internal standards support quantification, while isotope-labeled precursors can trace synthesis and turnover. Assigning chain positions or double-bond locations often requires specialized methods beyond routine profiling.

Physical studies complement compositional analysis. Nuclear magnetic resonance probes molecular motion and head-group environments; scattering and diffraction characterize bilayer dimensions and organization; calorimetry measures thermally driven transitions. Fluorescent probes and microscopic imaging reveal lateral organization and membrane dynamics. Sample handling remains consequential: oxidation, enzymatic degradation after collection, unequal extraction recovery, and instrument-dependent ionization can all alter apparent composition. A reported phosphatidylcholine concentration is therefore meaningful only in relation to the biological compartment, analytical method, and structural resolution of the measurement.

Bilayer organization and membrane properties

Phosphatidylcholine commonly accounts for roughly 40–50% of total phospholipid in mammalian cells, although its abundance varies substantially among tissues and organelles. Its principal structural role follows from the hydrophobic effect. In water, the hydrocarbon chains are energetically disfavored at the aqueous interface, whereas the head groups remain hydrated. Assemblies therefore form with chains shielded from water and head groups exposed to it. Because ordinary diacyl phosphatidylcholines have two hydrocarbon chains and a relatively large head group, they commonly form bilayers rather than the small spherical micelles typical of many single-chain detergents.

A bilayer is not a rigid sheet. Its molecules undergo rapid rotation and lateral diffusion, while their chains flex and change conformation. Spontaneous movement of the phosphocholine head group through the hydrophobic bilayer interior is much slower. In biological membranes, transport proteins accelerate or regulate movement between the two leaflets. This helps establish asymmetry: phosphatidylcholine is often enriched in the outer leaflet of the mammalian plasma membrane, whereas phosphatidylserine and much phosphatidylethanolamine are concentrated on the cytoplasmic side. The precise distribution differs among membranes and changes during membrane trafficking and cellular activation.

Acyl-chain structure strongly affects membrane behavior. Saturated chains can pack closely, whereas cis double bonds introduce bends that generally reduce packing efficiency. Fully hydrated, purified DPPC bilayers undergo their principal gel-to-liquid-crystalline phase transition at approximately 41 ∘C41\,^\circ\mathrm{C}. DOPC has a transition temperature well below 0 ∘C0\,^\circ\mathrm{C}, so its bilayers are fluid at ordinary laboratory temperatures. These values describe particular experimental systems, not fixed transition points for complex biological membranes. Mixed chain lengths, unsaturation, proteins, salts, and other lipids broaden or reorganize the behavior.

Cholesterol has particularly important interactions with phosphatidylcholine. Its rigid ring structure can increase the ordering of nearby hydrocarbon chains in fluid membranes, while disrupting the regular packing that would otherwise favor a gel phase. Depending on composition and temperature, mixtures can form liquid-ordered environments distinct from both disordered fluid bilayers and solid-like gels. Describing cholesterol simply as increasing or decreasing “fluidity” therefore omits the dependence on the initial membrane state and the particular property being measured.

Phosphatidylcholine also contributes to membrane thickness, bending elasticity, hydration forces, and permeability. Its approximately cylindrical molecular geometry often favors relatively low spontaneous curvature compared with lipids having smaller head groups or only one chain. Nevertheless, membrane shape is a collective property involving both leaflets, proteins, and neighboring lipids. The lipid environment can influence the conformational behavior of membrane proteins, including transporters and ion channels, without phosphatidylcholine serving as a specific ligand.

Biosynthesis and cellular distribution

The principal route of phosphatidylcholine synthesis in many animal cells is the CDP-choline pathway, commonly called the Kennedy pathway. Eugene Kennedy and Samuel Weiss established the central role of cytidine nucleotide intermediates in phospholipid synthesis in the 1950s. In this pathway, choline is first phosphorylated by choline kinase, using adenosine triphosphate. Phosphocholine then reacts with cytidine triphosphate to form CDP-choline and pyrophosphate. Finally, the phosphocholine group is transferred from CDP-choline to diacylglycerol, producing phosphatidylcholine and cytidine monophosphate.

The second reaction is catalyzed by CTP:phosphocholine cytidylyltransferase, often abbreviated CCT. It is a major regulatory point, although control of pathway flux is distributed among substrate supply, enzyme activities, and membrane conditions. Mammalian CCTα, encoded by PCYT1A, can associate reversibly with membranes through an amphipathic region. Its activity responds to membrane packing and lipid composition, helping connect phosphatidylcholine production to the physical state of cellular membranes. The final phosphotransfer reactions occur in membranes of the endoplasmic reticulum and Golgi system, depending on the enzyme involved.

A second route converts phosphatidylethanolamine to phosphatidylcholine by three successive methylations. In mammals, the enzyme phosphatidylethanolamine N-methyltransferase, or PEMT, is particularly important in the liver. Each methylation uses S-adenosylmethionine as methyl donor and produces S-adenosylhomocysteine. Thus, synthesis through PEMT connects membrane phospholipid production with one-carbon metabolism. In the liver this route typically contributes a substantial minority of phosphatidylcholine synthesis, often estimated at about 30%, but the proportion depends on physiological and experimental conditions. Its products can differ in acyl-chain composition from those initially generated through the CDP-choline pathway.

Pathway organization is not uniform across organisms. Plants can generate phosphocholine through methylation of phosphorylated ethanolamine intermediates, while yeasts possess both choline-dependent and phospholipid-methylation routes. Some bacteria synthesize phosphatidylcholine by methylating phosphatidylethanolamine. Others use phosphatidylcholine synthase, which combines choline with CDP-diacylglycerol. Many bacterial species contain little or no phosphatidylcholine, so its prominence in mammalian membranes should not be generalized to every cell.

Newly synthesized phosphatidylcholine must reach membranes beyond its site of production. Vesicular traffic distributes it through the secretory pathway, while lipid-transfer proteins and membrane-contact sites support nonvesicular exchange. The mitochondrion, for example, depends substantially on imported phosphatidylcholine. Within the endoplasmic reticulum, relatively rapid transbilayer lipid movement helps both leaflets expand. Subsequent sorting, selective transport, synthesis, and degradation establish the different compositions of the plasma membrane, intracellular organelles, and specialized secretory structures.

Remodeling, degradation, and signaling

The phosphatidylcholine produced by de novo synthesis is not necessarily the molecule that persists in a membrane. Its acyl chains undergo continual replacement through the Lands cycle, named for William E. M. Lands, whose work in the late 1950s established the importance of phospholipid deacylation and reacylation. A phospholipase removes an acyl chain, generating lysophosphatidylcholine; an acyltransferase then restores a second chain from an activated fatty acid donor. This allows cells to alter molecular species without reconstructing the entire glycerophosphocholine backbone.

Phospholipases are distinguished by the bonds they cleave. Phospholipase A₂ removes the fatty acyl group at the snsn-2 position, whereas phospholipase A₁ acts at snsn-1. Lysophosphatidylcholine acyltransferases, abbreviated LPCATs, reacylate lysophosphatidylcholine. Different isoforms have different tissue distributions and substrate preferences. LPCAT1 is important in the generation of saturated phosphatidylcholine species in pulmonary surfactant. Other remodeling enzymes help distribute polyunsaturated fatty acids among membrane phospholipids. Tissue-specific molecular composition therefore reflects selective remodeling as well as the substrates available during initial synthesis.

Deacylation can also connect phosphatidylcholine turnover to signaling. When a phospholipase releases a polyunsaturated fatty acid such as arachidonic acid, that fatty acid may enter pathways producing local signaling molecules. Phosphatidylcholine is one potential reservoir, alongside other phospholipid classes. Phospholipase D cleaves the bond between phosphate and choline, producing phosphatidic acid and free choline. Phosphatidic acid can recruit proteins, affect membrane curvature, or be converted to diacylglycerol. The effects depend on the enzyme, subcellular location, and timing; they cannot be inferred simply from a change in total cellular phosphatidylcholine.

Lysophosphatidylcholine is itself biologically consequential. With only one hydrocarbon chain, it has different packing properties from its diacyl precursor and, at sufficiently high concentrations, can disrupt membranes. In blood, much of it is associated with albumin or lipoproteins rather than existing as freely dissolved monomers. It is produced not only by phospholipases but also when lecithin–cholesterol acyltransferase transfers an acyl group from phosphatidylcholine to cholesterol. Further breakdown can yield glycerophosphocholine and eventually recover choline for reuse or oxidation.

Oxidative modification creates another set of products. Polyunsaturated acyl chains can undergo lipid peroxidation, producing hydroperoxides, shortened chains, and reactive carbonyl-containing phosphatidylcholines. These altered lipids can change membrane properties and interact with components of innate immunity. They are chemically diverse, however, and should not be treated as a single signaling substance. A modest change in the total phosphatidylcholine pool may coexist with large changes in particular oxidized species or in the rate at which the pool turns over.

Lipoproteins, bile, and pulmonary surfactant

Phosphatidylcholine performs specialized functions at interfaces outside ordinary cellular bilayers. In circulating lipoproteins, it is a major component of the surface monolayer surrounding a hydrophobic core of triacylglycerols and cholesteryl esters. Its hydrated head group faces blood plasma, while its hydrocarbon chains associate with the particle’s lipid interior. This architecture permits poorly water-soluble lipids to circulate in an aqueous environment. Exchange of surface lipids among particles, together with enzyme-catalyzed remodeling, contributes to the changing composition of lipoproteins during circulation.

The liver requires phosphatidylcholine for the assembly and secretion of very-low-density lipoproteins, which export triacylglycerol to other tissues. Both the CDP-choline and PEMT pathways contribute to hepatic phosphatidylcholine supply. Experimental disruption of synthesis can impair lipid export and alter the balance among membrane lipids. In high-density lipoproteins, lecithin–cholesterol acyltransferase transfers the snsn-2 fatty acyl group of phosphatidylcholine to free cholesterol, producing cholesteryl ester and lysophosphatidylcholine. The ester partitions into the particle’s interior, helping drive lipoprotein maturation.

Phosphatidylcholine is also the principal phospholipid in bile. The canalicular transporter ABCB4 promotes its movement toward the outer leaflet of the hepatocyte membrane facing the bile canaliculus, from which bile salts can extract it. Phosphatidylcholine participates in mixed micelles and vesicles containing bile salts and cholesterol. These assemblies help solubilize cholesterol and reduce the damaging effects of unassociated bile salts on biliary epithelia. Pathogenic variants in ABCB4 are associated with defined cholestatic disorders, illustrating that delivery to the correct compartment is as important as total phosphatidylcholine availability.

In the lung, pulmonary surfactant is a lipid–protein mixture secreted by alveolar type II cells. Phosphatidylcholine is its dominant phospholipid, and DPPC is especially important because its saturated chains can form tightly packed interfacial films during compression. By lowering surface tension at the air–liquid interface, surfactant reduces the pressure needed to maintain small air spaces. The idealized Laplace relation, ΔP=2γ/r\Delta P=2\gamma/r, shows the connection between pressure difference, surface tension γ\gamma, and radius rr, although real alveoli are interconnected structures rather than isolated spheres.

Effective surfactant is not simply pure DPPC. Unsaturated lipids and surfactant proteins facilitate adsorption, spreading, film reorganization, and recycling during breathing. Type II cells package surfactant in lamellar bodies and secrete it into the alveolar lining layer; uptake by these cells and by alveolar macrophages contributes to turnover. Insufficient functional surfactant is central to neonatal respiratory distress syndrome, especially in premature infants. Clinical surfactant preparations consequently reproduce aspects of a multicomponent biological material rather than relying only on the presence of phosphatidylcholine.

Dietary supply, digestion, and choline metabolism

Phosphatidylcholine is present in many foods, including eggs, meat, fish, soybeans, and other seeds. Its abundance varies with the biological material and processing method. Egg yolk and oilseed-derived lecithins are important commercial sources, but neither is chemically uniform. Dietary phosphatidylcholine is significant partly because it supplies choline, a nutrient used in phospholipid synthesis, production of the neurotransmitter acetylcholine, and metabolism of methyl groups. Choline content must be distinguished from phosphatidylcholine mass: most of the mass of a phosphatidylcholine molecule lies in its lipid backbone and fatty acyl chains.

Digestion involves emulsification by bile components and enzymatic hydrolysis in the small intestine. Pancreatic phospholipase A₂ commonly removes the snsn-2 acyl chain, producing lysophosphatidylcholine and a free fatty acid. These products associate with mixed micelles and can be taken up by intestinal epithelial cells. Lysophosphatidylcholine may be reacylated to phosphatidylcholine, which can then enter intestinal membranes or newly assembled chylomicrons. Additional pathways release glycerophosphocholine and free choline. The relative contributions depend on substrate composition and the digestive environment.

Dietary phosphatidylcholine is therefore not simply absorbed intact and delivered unchanged to a particular organ. Digestion, reacylation, lipoprotein transport, tissue uptake, and further remodeling redistribute its components. Stable-isotope experiments can distinguish the fate of labeled choline from that of labeled fatty acids, demonstrating why detection of a dietary label in tissue does not necessarily establish uptake of the original complete molecule. Endogenous phosphatidylcholine secreted in bile also enters the intestinal lumen, so the intestine processes both dietary and recycled material.

Humans synthesize phosphatidylcholine through PEMT, but this route does not eliminate the requirement for dietary choline. Controlled depletion studies have established that inadequate choline intake can produce liver dysfunction and, in some individuals, muscle injury. Requirements vary with factors including life stage, hormonal state, and genetic variation affecting choline and one-carbon metabolism. The United States Institute of Medicine established adequate-intake values for choline in 1998: 550 mg per day for adult men and 425 mg per day for adult women, with separate values for pregnancy and lactation. These are population reference values for total choline, not prescribed amounts of phosphatidylcholine.

Some intestinal microorganisms convert choline to trimethylamine, which is absorbed and oxidized mainly in the liver to trimethylamine N-oxide, or TMAO. Phosphatidylcholine can supply choline to this pathway. Human studies show associations between circulating TMAO and several disease outcomes, but these observations do not establish that all phosphatidylcholine-containing foods have equivalent effects or that TMAO alone explains the associations. Microbial composition, kidney function, dietary context, and host metabolism all influence measured concentrations. Nutrient chemistry, microbial transformation, and clinical outcomes are distinct levels of analysis.

Biological dysfunction and clinical interpretation

Disturbances of phosphatidylcholine metabolism can arise from impaired synthesis, altered transport, excessive degradation, or changes in molecular-species composition. These disturbances are not interchangeable. A tissue may retain a nearly normal total concentration while losing a functionally important subset of molecules or distributing them incorrectly among organelles. Likewise, the phosphatidylcholine-to-phosphatidylethanolamine ratio can influence membrane organization independently of the absolute amount of either lipid. Experimental interpretation therefore requires attention to location, composition, and turnover rather than a single bulk measurement.

Rare inherited disorders provide direct evidence that particular steps are physiologically essential. Biallelic pathogenic variants in PCYT1A can cause spondylometaphyseal dysplasia with cone-rod dystrophy, linking defective CDP-choline pathway activity to skeletal and retinal abnormalities. Variants in ABCB4 impair phospholipid secretion into bile and underlie progressive familial intrahepatic cholestasis type 3 and related hepatobiliary phenotypes. These conditions affect different processes: one concerns phosphatidylcholine biosynthesis, while the other primarily concerns its transport at a specialized membrane.

The liver has been a major focus of research because it both synthesizes phosphatidylcholine and exports large quantities in bile and lipoproteins. Choline depletion and experimental impairment of phosphatidylcholine synthesis can promote hepatic triacylglycerol accumulation. However, common fatty liver disease is multifactorial, involving energy balance, insulin-related metabolism, genetic susceptibility, and other processes. A mechanistic requirement for phosphatidylcholine in lipoprotein secretion does not establish that phosphatidylcholine supplementation treats every form of hepatic fat accumulation. Similar care is required when interpreting experimental effects in cultured cells or animals.

Phosphatidylcholine profiles have also been studied as potential biomarkers in metabolic, neurological, inflammatory, and malignant diseases. Such studies frequently measure individual molecular species or groups of species rather than total phosphatidylcholine. A difference between patient and control samples may reflect altered lipoprotein abundance, tissue injury, medication exposure, diet, or changes in lipid metabolism. Some analytical platforms report unresolved lipid sums, making apparently similar labels chemically non-equivalent. Reproducibility, independent validation, and demonstration of clinical utility are separate requirements beyond finding a statistically significant association.

Phosphatidylcholine-containing supplements and preparations have been investigated for multiple indications, but evidence must be interpreted for each formulation and condition. Lecithin, purified phosphatidylcholine, lysophosphatidylcholine, and free choline are not interchangeable interventions. Nor does delivery in an injection or vesicle reproduce oral exposure. The established physiological importance of a membrane constituent is distinct from evidence that additional administration improves a clinical outcome. Clinical trials also require appropriate comparators because solvents, detergents, co-administered compounds, and the carrier system itself may contribute to observed effects.

Industrial materials and pharmaceutical formulations

Commercial phosphatidylcholine is obtained chiefly by fractionating natural lecithins or by chemical and enzymatic synthesis. Oilseed processing produces phospholipid-rich material during degumming, while egg yolk supplies an alternative mixture with a different molecular-species profile. Further solvent fractionation or chromatographic purification enriches phosphatidylcholine relative to phosphatidylethanolamine, phosphatidylinositol, neutral lipids, and other constituents. Hydrogenation reduces acyl-chain unsaturation and changes oxidative stability and thermal behavior. Fully synthetic products provide more precisely defined chains and are particularly useful when reproducible physical properties are required.

In food systems, lecithins act as emulsifiers, dispersing agents, and modifiers of interfacial behavior. Their phosphatidylcholine content contributes to these properties, but performance depends on the entire mixture. In chocolate, for example, lecithin can alter the interactions among solid particles and the continuous fat phase, changing flow behavior. In other formulations, phospholipids help organize oil–water interfaces or disperse powders. A lecithin’s effectiveness therefore cannot be predicted solely from the mass fraction of phosphatidylcholine without considering other phospholipids, residual oil, water content, and processing conditions.

Purified phosphatidylcholine is a central material in liposomes, closed vesicles bounded by one or more lipid bilayers. Work by Alec Bangham and colleagues in the 1960s helped establish these structures as experimental membrane systems. Liposomes can enclose water-soluble substances in their aqueous interior and incorporate hydrophobic substances within the bilayer. Their permeability, size, stability, and interaction with proteins depend on lipid composition and preparation. Cholesterol and surface-modifying lipids are often added, so the behavior of a practical formulation cannot be assigned to phosphatidylcholine alone.

Pharmaceutical formulations exploit this tunability. Saturated or hydrogenated phosphatidylcholines can provide comparatively stable bilayers, whereas more unsaturated species yield different packing and thermal characteristics. Phosphatidylcholines also serve as helper lipids in some nucleic-acid lipid nanoparticles, alongside ionizable lipids, cholesterol, and polyethylene-glycol-linked lipids. In such particles, the helper phospholipid contributes structural organization, while other components perform distinct functions in nucleic-acid association, colloidal stability, and intracellular delivery. A lipid nanoparticle need not have the same internal organization as a conventional hollow liposome.

Manufacturing imposes requirements beyond chemical identity. Oxidation of unsaturated chains, hydrolysis to lysophosphatidylcholine, residual solvents, microbial contamination, and variation among natural-source batches can affect product performance. Analytical specifications may therefore include phosphatidylcholine purity, fatty acid composition, peroxide-related measurements, lysophospholipid content, water content, and particle characteristics. For research, defined phosphatidylcholines also form planar bilayers, supported membranes, and membrane-protein reconstitution systems. The choice of lipid determines the experimental environment: a protein embedded in pure POPC experiences a much simpler surrounding membrane than it does in a living cell.